Cardiovascular Systems

Selected news for Cardiovascular Systems, representing 4% of data collected since 10/2017. Recent stories appear in Mayfield Recorder and Dakota Financial News. This company shares news with Medtronic, Boston Scientific, Terumo and many others.

Please provide a valid email address.

Selected Headines

Date Headline (link) Source Relevant Snippet
1/13/2021 Cardiovascular Systems (NASDAQ:CSII) and Penumbra (NYSE:PEN) Critical Contrast thelincolnianonline.com 0 3.00Penumbra presently has a consensus target price of $235.33, indicating a potential upside of 10.18%. Cardiovascular Systems has a consensus target price of $47.00, indicating a potential upside of 4.79%. Given Penumbra’s higher possible upside, research analysts plainly believe Penumbra is more favorable than Cardiovascular Systems .Risk and VolatilityPenumbra has a beta of 0.67, suggesting that its share price is 33% less volatile than the S ...
1/13/2021 Comparing Penumbra (NYSE:PEN) & Cardiovascular Systems (NASDAQ:CSII) theenterpriseleader.com Penumbra beats Cardiovascular Systems on 10 of the 14 factors compared between the two stocks.Cardiovascular Systems Company ProfileCardiovascular Systems, Inc., a medical device company, develops and commercializes various devices to treat peripheral and coronary artery diseases in the United States. The company offers peripheral artery disease products, which are catheter-based platforms to treat a range of plaque types in above and below the knee leg arteries, including ...
1/13/2021 Oppenheimer Sticks to Its Sell Rating for Intuitive Surgical (ISRG) markets.co ... Kalia is a 4-star analyst with an average return of 9.2% and a 57.1% success rate. Kalia covers the Healthcare sector, focusing on stocks such as Tactile Systems Technology, Inspire Medical Systems, and Cardiovascular Systems .The word on The Street in general, suggests a Moderate Buy analyst consensus rating for Intuitive Surgical with a $696.25 average price target.See today’s analyst top recommended stocks
Based on Intuitive Surgical ...
1/12/2021 Analysts Have Conflicting Sentiments on These Healthcare Companies: GW Pharma (GWPH) and OrthoPediatrics (KIDS) markets.co ... 43.75.According to TipRanks.com , Matson is a 5-star analyst with an average return of 15.6% and a 69.1% success rate. Matson covers the Healthcare sector, focusing on stocks such as Axonics Modulation Technologies, Cardiovascular Systems , and Zimmer Biomet Holdings.The word on The Street in general, suggests a Strong Buy analyst consensus rating for OrthoPediatrics with a $56.00 average price target.TipRanks has tracked 36,000 company insiders and found ...
1/12/2021 OrthoPediatrics (KIDS) Gets a Buy Rating from Needham markets.co ... 43.75.According to TipRanks.com , Matson is a 5-star analyst with an average return of 15.6% and a 69.1% success rate. Matson covers the Healthcare sector, focusing on stocks such as Axonics Modulation Technologies, Cardiovascular Systems , and Zimmer Biomet Holdings.OrthoPediatrics has an analyst consensus of Strong Buy, with a price target consensus of $56.00.See today’s analyst top recommended stocks
Based on OrthoPediatrics’ latest earnings release for ...
1/12/2021 Coronary Artery Bypass Graft Market analysis by stage of development nysenewstimes.com ... to assess and analyze market. It also describes player/manufacturers strategy in the light of Porters, Value Chain & SWOT analysis, and based on that recommendation on players is derived like Hancock Jaffe Laboratories, Terumo Cardiovascular Systems , VasoPrep Surgical, Dextera Surgical, Neograft, NOVADAQ Technologies, MAQUET Holding, Genesee BioMedical, Sorin Group & Edwards Lifesciences Corporation.Avail Free sample copy before purchase: https://www.htfmarketreport.com/sample-report/2504534-global-coronary-artery-bypass-graft-market-8 ...
1/12/2021 Steris (STE) Gets a Hold Rating from Needham markets.co ... 203.91.According to TipRanks.com , Matson is a 5-star analyst with an average return of 15.4% and a 68.8% success rate. Matson covers the Healthcare sector, focusing on stocks such as Axonics Modulation Technologies, Cardiovascular Systems , and Zimmer Biomet Holdings.The the analyst consensus on Steris is currently a Hold rating.See today’s analyst top recommended stocks
Steris’ market cap is currently $17.1B and has a P/E ...
1/11/2021 Cardiovascular Systems (NASDAQ:CSII) Upgraded by BidaskClub to Strong-Buy theenterpriseleader.com Cardiovascular Systems (NASDAQ:CSII) Upgraded by BidaskClub to Strong-Buy Posted by Jeanne O'Marion on Jan 11th, 2021BidaskClub upgraded shares of Cardiovascular Systems (NASDAQ:CSII) from a buy rating to a strong-buy rating in a research report sent to investors on Thursday, BidAskClub reports.Several other research analysts have also issued reports on the company. Northland Securities increased their target price on Cardiovascular Systems from $40.00 to $45.00 ...
1/11/2021 Natus Medical (NTUS) Receives a Hold from Raymond James markets.co ... last Friday at $23.97.According to TipRanks.com , Bedford is a 5-star analyst with an average return of 16.8% and a 74.2% success rate. Bedford covers the Healthcare sector, focusing on stocks such as Cardiovascular Systems , Merit Medical Systems, and Edwards Lifesciences.The word on The Street in general, suggests a Hold analyst consensus rating for Natus Medical.See today’s analyst top recommended stocks
Natus Medical’s market cap ...
1/11/2021 Analysts Offer Insights on Healthcare Companies: Atricure (ATRC) and IDEAYA Biosciences (IDYA) markets.co ... 58.03.According to TipRanks.com , Matson is a 5-star analyst with an average return of 15.6% and a 69.1% success rate. Matson covers the Healthcare sector, focusing on stocks such as Axonics Modulation Technologies, Cardiovascular Systems , and Zimmer Biomet Holdings.Atricure has an analyst consensus of Strong Buy, with a price target consensus of $57.67, which is a 3.1% upside from current levels. In a report released today, BTIG also ...
1/11/2021 Oppenheimer Assigns a Buy Rating on Atricure (ATRC) markets.co ... Kalia is a 4-star analyst with an average return of 8.7% and a 57.3% success rate. Kalia covers the Healthcare sector, focusing on stocks such as Tactile Systems Technology, Inspire Medical Systems, and Cardiovascular Systems .The word on The Street in general, suggests a Strong Buy analyst consensus rating for Atricure with a $59.00 average price target, implying a 5.5% upside from current levels. In a report released today ...
1/11/2021 Analysts’ Top Healthcare Picks: Baxter International (BAX), Aerie Pharma (AERI) markets.co ... Kalia is a 4-star analyst with an average return of 8.7% and a 57.3% success rate. Kalia covers the Healthcare sector, focusing on stocks such as Tactile Systems Technology, Inspire Medical Systems, and Cardiovascular Systems .Currently, the analyst consensus on Baxter International is a Strong Buy with an average price target of $94.00.See today’s analyst top recommended stocks
Aerie Pharma (AERI)In a report released today, Difei ...
1/10/2021 Diversified Trust Co Purchases 700 Shares of Cardiovascular Systems, Inc. (NASDAQ:CSII) Mayfield Recorder Diversified Trust Co Purchases 700 Shares of Cardiovascular Systems, Inc. (NASDAQ:CSII) Posted by Charles Blunt on Jan 10th, 2021Diversified Trust Co lifted its position in Cardiovascular Systems, Inc. (NASDAQ:CSII) by 4.7% during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 15,625 shares of the medical device company’s stock after purchasing an additional 700 shares during the ...
1/9/2021 Cardiovascular Systems, Inc. (NASDAQ:CSII) Given Average Recommendation of “Buy” by Brokerages thelincolnianonline.com Cardiovascular Systems, Inc. (NASDAQ:CSII) Given Average Recommendation of “Buy” by Brokerages Posted by Alanna Baker on Jan 9th, 2021 TweetShares of Cardiovascular Systems , Inc. (NASDAQ:CSII) have earned a consensus recommendation of “Buy” from the eleven brokerages that are covering the company, Marketbeat Ratings reports. One analyst has rated the stock with a sell recommendation, eight have given a buy recommendation and one has assigned a ...
1/8/2021 BidaskClub Upgrades Cardiovascular Systems (NASDAQ:CSII) to “Strong-Buy” wkrb13.com BidaskClub upgraded shares of Cardiovascular Systems (NASDAQ:CSII) from a buy rating to a strong-buy rating in a research note issued to investors on Thursday, BidAskClub reports.Several other analysts also recently issued reports on CSII. Needham & Company LLC upped their price target on shares of Cardiovascular Systems from $44.00 to $47.00 and gave the company a buy rating in a report on Thursday, November 5th. SVB Leerink upped ...
1/8/2021 Head to Head Contrast: Cardiovascular Systems (NASDAQ:CSII) and Becton, Dickinson and (NYSE:BDX) Daily Political ... both medical companies, but which is the superior investment? We will compare the two companies based on the strength of their valuation, institutional ownership, dividends, earnings, profitability, analyst recommendations and risk. Risk and Volatility Cardiovascular Systems has a beta of 1.19, meaning that its stock price is 19% more Becton, Dickinson and has a beta of 0.79, meaning that its stock price is 21% Cardiovascular Systems and Becton, Dickinson and ...
1/6/2021 Becton, Dickinson and (NYSE:BDX) & Cardiovascular Systems (NASDAQ:CSII) Head to Head Comparison zolmax.com 0.79) -56.08Becton, Dickinson and has higher revenue and earnings than Cardiovascular Systems. Cardiovascular Systems is trading at a lower price-to-earnings ratio than Becton, Dickinson and, indicating that it is currently the more affordable of the two stocks.Institutional and Insider Ownership74.4% of Becton, Dickinson and shares are held by institutional investors. Comparatively, 85.5% of Cardiovascular Systems shares are held by institutional investors. 0.8% of Becton, Dickinson ...
1/6/2021 Analysts Offer Insights on Healthcare Companies: NuVasive (NASDAQ: NUVA) and Cerecor (NASDAQ: CERC) analystratings.com ... 57.88.According to TipRanks.com , Matson is a 5-star analyst with an average return of 14.2% and a 68.6% success rate. Matson covers the Healthcare sector, focusing on stocks such as Axonics Modulation Technologies, Cardiovascular Systems , and Zimmer Biomet Holdings.Currently, the analyst consensus on NuVasive is a Moderate Buy with an average price target of $60.83, representing a 12.4% upside. In a report released yesterday, Cowen & Co. also maintained ...
1/6/2021 Analysts Offer Insights on Healthcare Companies: Hologic (NASDAQ: HOLX), Millendo Therapeutics (NASDAQ: MLND) and RegenXBio (NASDAQ: RGNX) analystratings.com ... week high of $77.49.According to TipRanks.com , Bedford is a 5-star analyst with an average return of 16.2% and a 73.0% success rate. Bedford covers the Healthcare sector, focusing on stocks such as Cardiovascular Systems , Merit Medical Systems, and Edwards Lifesciences.The word on The Street in general, suggests a Moderate Buy analyst consensus rating for Hologic with a $90.11 average price target.See today’s analyst top recommended ...
1/4/2021 Becton, Dickinson and (NYSE:BDX) vs. Cardiovascular Systems (NASDAQ:CSII) Head-To-Head Analysis rivertonroll.com 8.36%SummaryBecton, Dickinson and beats Cardiovascular Systems on 8 of the 13 factors compared between the two stocks.Becton, Dickinson and Company ProfileBecton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products worldwide. The company's BD Medical segment offers peripheral intravenous (IV) and advanced peripheral catheters, central lines, acute dialysis catheters, vascular care and preparation products, needle-free IV connectors and extensions ...